Behl, A. S., Ellis, L. A., Pilon, D., Xiao, Y., & Lefebvre, P. (2017). Medication Adherence, Treatment Patterns, and Dose Reduction in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Acetate or Enzalutamide. Am Health Drug Benefits.
Citação norma ChicagoBehl, Ajay S., Lorie A. Ellis, Dominic Pilon, Yongling Xiao, and Patrick Lefebvre. "Medication Adherence, Treatment Patterns, and Dose Reduction in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Acetate or Enzalutamide." Am Health Drug Benefits 2017.
ציטוט MLABehl, Ajay S., et al. "Medication Adherence, Treatment Patterns, and Dose Reduction in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Acetate or Enzalutamide." Am Health Drug Benefits 2017.